Newsletter - All News

Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research

Category

Continent

From

To

EVEREST phase 4 study of Dupixent shows positive r...

EVEREST phase 4 study of Dupixent shows positive r...

Category : Clinical Trial Update 18 June 2025

Overview Sanofi and Regeneron Pharmaceuticals, Inc. presented positive results from the EVERES...

Emory & Micron Start First Human Trial of Rotaviru...

Emory & Micron Start First Human Trial of Rotaviru...

Category : Clinical Trial Update 18 June 2025

Overview Emory University and Micron Biomedical today announced the first clinical trial of a nov...

Ascletis Doses First Participants in U.S. Phase I...

Ascletis Doses First Participants in U.S. Phase I...

Category : Clinical Trial Update 18 June 2025

Overview Ascletis Pharma Inc. (HKEX: 1672, ""Ascletis"") announces that the f...

Skyhawk Therapeutics Announces SKY-0515 dosing in...

Skyhawk Therapeutics Announces SKY-0515 dosing in...

Category : Clinical Trial Update 18 June 2025

Overview Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel smal...

Innovent completes first patient dosing in seventh...

Innovent completes first patient dosing in seventh...

Category : Clinical Trial Update 18 June 2025

Overview Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company that dev...

1
2
›

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.